Detailed Information

Cited 25 time in webofscience Cited 25 time in scopus
Metadata Downloads

Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea

Authors
Hong, S. N.Kim, H. J.Kim, K. H.Han, S. -J.Ahn, I. M.Ahn, H. S.
Issue Date
Jan-2017
Publisher
WILEY-BLACKWELL
Citation
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, v.45, no.2, pp 253 - 263
Pages
11
Indexed
SCI
SCIE
SCOPUS
Journal Title
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume
45
Number
2
Start Page
253
End Page
263
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/5441
DOI
10.1111/apt.13851
ISSN
0269-2813
1365-2036
Abstract
Background The low incidence of Mycobacterium tuberculosis infection and lack of adequate controls have prevented researchers from estimating tuberculosis (TB) risk in inflammatory bowel disease (IBD) patients. Aim To evaluate the risk of incident TB among IBD patients. Methods Using the 2011-2013 data of the South Korean National Health Insurance (NHI) system, we calculated the incidence rates (IRs), standardised incidence ratio (SIR) and number needed to screen (NNS) for incident TB in IBD patients compared to the general population in terms of subtype, age, gender and IBD medications. Results The IR, SIR and NNS for TB in IBD patients were 223.9/100 000 person-years, 2.64 (2.30-3.01) and 446.6 (392.8-517.6), respectively. The TB IR in Crohn's disease (CD) patients was significantly higher than that in ulcerative colitis (UC) patients (340.1/100 000 person-years vs. 165.5/100 000 person-years, respectively; P < 0.001). The SIR and NNS for TB among CD patients were 4.00 (3.59-4.45) and 604.2 (506.1-749.6), respectively; those among UC patients were 1.95 (1.66-2.27) and 294.0 (246.9-363.4). The TB IRs in IBD patients did not differ significantly by age or gender (Ptrend = 0.505 and P = 0.861, respectively). The TB IRs among IBD patients prescribed 5-ASA, corticosteroids, immunomodulators and anti-TNF-alpha were 143.5, 208.5, 284.6 and 554.1 per 100 000 person-years, respectively. Among IBD patients treated using anti-TNF-alpha, the TB IR was significantly higher than that among all IBD patients (P < 0.001); the SIR and NNS for TB were 6.53 (5.99-7.09) and 180.5 (144.6-240.1) respectively. Conclusion Clinicians should be aware of the increased risk of active tuberculosis in patients with IBD who are receiving anti-TNF-alpha therapy.
Files in This Item
There are no files associated with this item.
Appears in
Collections
1. Basic Science > Department of Preventive Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE